Trials / Completed
CompletedNCT00525278
To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis
Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Seasonal Allergic Rhinitis (SAR)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine dihydrochloride |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2003-10-01
- Completion
- 2003-10-01
- First posted
- 2007-09-05
- Last updated
- 2013-12-16
Source: ClinicalTrials.gov record NCT00525278. Inclusion in this directory is not an endorsement.